UnitedHealth Group Stock Rises Above $400 as Earnings and Guidance Exceed Expectations

UnitedHealth Group's stock is holding strong above $400 following its Q2 2026 earnings report, which exceeded expectations and provided a clearer recovery path for the health insurer. The company reported earnings per share of $6.38, compared to consensus estimates of $4.94, representing a beat of $1.44 per share. Revenue also came in slightly above expectations at $112.03 billion.

The Q2 2026 numbers show improved profitability, with a net margin of 3.14% and return on equity reaching 16.53%. Management signaled that margins in the Medicare book are on track to finish above 3% for 2026, which is good news for investors as Medicare Advantage has been a key swing factor for earnings and valuation.

The company's updated full-year 2026 guidance sets an earnings per share range of $19.50 to $20.00, which reflects management's view of improved operating conditions. UnitedHealth Group shares have responded positively to the stronger outlook and margin improvements, delivering a notable recovery in 2026 with a year-to-date increase of 21.6%.